연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1613 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Osseointegrative and immunomodulative 3D-Printing Ti6Al4V-based implants embedded with biogenic hydroxyapatite | Seonwoo, Hoon | Seonwoo, H | 11 | 교신저자 | Sunchon Natl Univ, Coll Life Sci & Nat Resources, Dept Convergent Biosyst Engn, Sunchon 57922, South Korea | jchung@snu.ac.kr;paik815@scnu.ac.kr;jungsil.kim@knu.ac.kr;uhun906@scnu.ac.kr; | ||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Hwang, Sang Youn | Hwang, SY | 1 | Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan 46033, South Korea | 0000-0003-2750-9379 | HWANG, SANGYOUN | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Woo, Hyun Young | Woo, HY | 2 | Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Coll Med, Busan 49241, South Korea | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Heo, Jeong | Heo, J | 3 | 교신저자 | Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Coll Med, Busan 49241, South Korea | MHQ-1390-2025 | Heo, Jeong | 0000-0003-0961-7851 | Heo, Jeong | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; |
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Kim, Hyung Jun | Kim, HJ | 4 | Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan 46033, South Korea | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Park, Young Joo | Park, YJ | 5 | Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Coll Med, Busan 49241, South Korea | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Yi, Ki Youn | Yi, KY | 6 | Pusan Natl Univ, Pusan Natl Univ Hosp, Biomed Res Inst, Coll Med, Busan 49241, South Korea | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Lee, Yu Rim | Lee, YR | 7 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea | 0000-0003-1916-1448 | Lee, Yu Rim | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Park, Soo Young | Park, SY | 8 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea | 0000-0002-4944-4396 | Park, Soo Young | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Chung, Woo Jin | Chung, WJ | 9 | Keimyung Univ, Dept Internal Med, Sch Med, Daegu 42601, South Korea | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Jang, Byoung Kuk | Jang, BK | 10 | Keimyung Univ, Dept Internal Med, Sch Med, Daegu 42601, South Korea | 0000-0002-8950-0866 | Jang, Byoung Kuk | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | |||
| Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Tak, Won Young | Tak, WY | 11 | 교신저자 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea | 0000-0002-1914-5141 | Tak, Won Young | mongmani@daum.net;who54@hanmail.net;jheo@pusan.ac.kr;phorni@naver.com;juya0630@naver.com;yikiyoun@hanmail.net;deblue00@naver.com;psyoung0419@gmail.com;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;wytak@knu.ac.kr; | ||
| Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study | Yi, Jun Ho | Yi, JH | 1 | Chung Ang Univ, Dept Med, Div Hematol Oncol, Seoul, South Korea | GXZ-8144-2022 | Yi, Jun Ho | 0000-0003-1499-7131 | Yi, Jun Ho | kihyunkimk@gmail.com; | |
| Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study | Lee, Jung Lim | Lee, JL | 2 | Dept Hematooncol, Daegu Fatima, Daegu, South Korea | Q-1055-2018 | Lee, Jeong-Hoon | kihyunkimk@gmail.com; | |||
| Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study | Lee, Yoo Jin | Lee, YJ | 3 | Ulsan Univ Hosp, Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan, South Korea | kihyunkimk@gmail.com; |
페이지 이동: